Skip Navigation

A Phase II Study of the Hepcidin Mimetic PTG-300 in Patients with Phlebotomy-Requiring Polycythemia Vera

Brief Summary

Type:
Hematologic - Other

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04057040

Study #:
STUDY00144246

Start Date:
Nov 20, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04057040

View Complete Trial Details & Eligibility at ClinicalTrials.gov